Anti-Suicide Drugs Market to Witness an Outstanding Growth During 2028 | Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company

-

 


Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Anti-depressants and anti-psychotics are the most widely used medications for treating suicidal tendencies. According to the World Health Organization (WHO), over 800,000 people die due to suicide annually. Development of an effective anti-suicidal drug could be a major breakthrough in reducing the death toll.

Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/10

Market Dynamics

Off-label use of these drugs for suicidal ideation has been a practice for years, as there are no approved anti-suicide specific drug yet. However, the dynamics is expected to change in the following few years with the launch of first oral therapeutic drug for acute suicidal ideation. This would disrupt the use of antidepressants and anti-psychotic drugs for the treatment of suicidal tendencies. Suicidal incidences are high in low and middle income countries according to the WHO 2016 statistics.

Key features of the study:

  • This report provides in-depth analysis of the anti-suicide drugs and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2027, considering 2018 as the base year

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

Request PDF Brochure Of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/10

Detailed Segmentation:

  • Global Anti-Suicide Drugs Market, By Drug Class:

    • Anti-Depressants and Anti-Anxiety Drugs

    • Anti-Psychotic Drugs

    • NMDA Antagonist

    • Antibiotic Analog

  • Global Anti-Suicide Drugs Market, By Geography:

    • North America

      • U.S.

        • U.S. Anti-Suicide Drugs Market, By Drug Class:

          • Anti-Depressant and Anti-Anxiety Drugs

          • Anti-Psychotic Drugs

          • NMDA Antagonist

          • Antibiotic Analog

Key Players included in the Anti-Suicide Drugs Market:

Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson.

Anti-Suicide Drugs Market Regional Analysis:

In the report, the geographical outlook of the Anti-Suicide Drugs report is segmented into regions like North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Some of the important questions addressed in the report are:

  1. What factors drive the market’s growth?

  2. What will be the market size in 2028?

  3. What is the expected market growth rate during the forecast period?

  4. What was the market size of Anti-Suicide Drugs in 2020?
    In which region will the Market have the largest market share?

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/insight/buy-now/10

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Phone: US +12067016702 / UK +4402081334027

Email: sales@coherentmarketinsights.com


Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more